Additionally, Kovaleva and colleagues reported that median soluble B7-H3 (sB7-H3) levels were significantly elevated in the blood of CRC patients compared to healthy donors, suggesting its potential role as a disease marker [11]. This evidence concerns the gene CD276 and colorectal carcinoma.